share_log

Kemper Analyst Ratings

Benzinga ·  Oct 24, 2023 09:00
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/24/2023 80.07% JMP Securities $85 → $75 Maintains Market Outperform
10/06/2023 12.85% Piper Sandler $55 → $47 Upgrades Neutral → Overweight
07/12/2023 104.08% JMP Securities → $85 Reiterates Market Outperform → Market Outperform
07/06/2023 32.05% Piper Sandler $52 → $55 Maintains Neutral
05/09/2023 24.85% Piper Sandler $62 → $52 Maintains Neutral
05/08/2023 87.27% Credit Suisse → $78 Reiterates → Outperform
05/01/2023 68.07% Raymond James $80 → $70 Maintains Strong Buy
04/18/2023 104.08% JMP Securities → $85 Reiterates → Market Outperform
04/10/2023 87.27% Credit Suisse $56 → $78 Upgrades Neutral → Outperform
04/04/2023 48.86% Piper Sandler $60 → $62 Maintains Neutral
03/14/2023 104.08% JMP Securities → $85 Reiterates → Market Outperform
03/10/2023 34.45% Credit Suisse → $56 Reiterates → Neutral
02/07/2023 92.08% Raymond James $60 → $80 Upgrades Outperform → Strong Buy
02/06/2023 104.08% JMP Securities → $85 Reiterates → Market Outperform
01/30/2023 34.45% Credit Suisse $44 → $56 Upgrades Underperform → Neutral
11/04/2022 44.06% Raymond James → $60 Upgrades Market Perform → Outperform
08/02/2022 15.25% Piper Sandler $57 → $48 Maintains Neutral
05/03/2022 104.08% JMP Securities $90 → $85 Maintains Market Outperform
04/28/2022 5.64% Credit Suisse → $44 Initiates Coverage On → Underperform
02/01/2022 Raymond James Downgrades Outperform → Market Perform
11/01/2021 56.06% Piper Sandler $75 → $65 Downgrades Overweight → Neutral
08/02/2021 80.07% Raymond James $80 → $75 Maintains Outperform
07/19/2021 92.08% Raymond James $90 → $80 Downgrades Strong Buy → Outperform
05/04/2021 116.09% Raymond James $95 → $90 Maintains Strong Buy
03/11/2021 128.09% Raymond James $85 → $95 Maintains Strong Buy
10/19/2020 104.08% Raymond James $95 → $85 Maintains Strong Buy
08/06/2020 128.09% Raymond James $80 → $95 Maintains Strong Buy
04/24/2020 92.08% Raymond James $85 → $80 Maintains Strong Buy
04/16/2020 116.09% JMP Securities $95 → $90 Maintains Market Outperform
04/06/2020 70.47% Piper Sandler $85 → $71 Maintains Overweight
04/03/2020 104.08% Raymond James $100 → $85 Maintains Strong Buy
09/10/2019 108.88% UBS → $87 Initiates Coverage On → Buy
09/09/2019 108.88% UBS → $87 Initiates Coverage On → Buy
08/23/2019 William Blair Downgrades Outperform → Market Perform
02/12/2019 96.88% JMP Securities $78 → $82 Maintains Market Outperform
01/08/2019 JMP Securities Upgrades Market Perform → Outperform
11/02/2018 92.08% Keefe, Bruyette & Woods → $80 Initiates Coverage On → Market Perform

What is the target price for Kemper (KMPR)?

The latest price target for Kemper (NYSE: KMPR) was reported by JMP Securities on October 24, 2023. The analyst firm set a price target for $75.00 expecting KMPR to rise to within 12 months (a possible 80.07% upside). 16 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Kemper (KMPR)?

The latest analyst rating for Kemper (NYSE: KMPR) was provided by JMP Securities, and Kemper maintained their market outperform rating.

When is the next analyst rating going to be posted or updated for Kemper (KMPR)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kemper, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kemper was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.

Is the Analyst Rating Kemper (KMPR) correct?

While ratings are subjective and will change, the latest Kemper (KMPR) rating was a maintained with a price target of $85.00 to $75.00. The current price Kemper (KMPR) is trading at is $41.65, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment